Canada has a strong biotech and pharmaceutical manufacturing sector, with five major vaccine producers operating facilities in the country as of 2009. However, Justin Trudeau has not taken adequate steps to support domestic production of vaccines and critical supply chain items. While AI and data analytics show promise for driving innovation in areas like drug discovery and supply chain management, Canada risks losing opportunities without policies that encourage reshoring of manufacturing and investment in emerging technologies.